ARVINDREM Intraday Analysis...


Open N/A Change Price %
High N/A 1 Day N/A N/A
Low N/A 1 Week N/A N/A
Close N/A 1 Month N/A N/A
Volume N/A 1 Year N/A N/A
52 Week High N/A
52 Week Low N/A
ARVINDREM Important Levels
Resistance 2 N/A
Resistance 1 N/A
Pivot N/A
Support 1 N/A
Support 2 N/A
NSE INDIA Most Active Stocks
RCOM 14.30 %
IFCI 18.90 %
IDEA 59.75 %
PFC 75.55 %
PFC 75.55 %
PFC 75.55 %
VEDL 251.80 %
GMRINFRA 17.90 %
NSE INDIA Top Gainers Stocks
NSE INDIA Top Losers Stocks

Arvind Remedies Limited (NSE: ARVINDREM)

ARVINDREM Technical Analysis 1
As on N/A ARVINDREM Share Price closed @ N/A and we RECOMMEND N/A for LONG-TERM with Stoploss of N/A & N/A for SHORT-TERM with Stoploss of N/A we also expect STOCK to react on Following IMPORTANT LEVELS.
ARVINDREM Target for May
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
Arvind Remedies Limited ( NSE INDIA Symbol : ARVINDREM )
Sector : Pharmaceuticals And Other Stocks in Same Sector
ARVINDREM Synopsis Technicals View
50 Day EMA N/A (Short Term)
100 Day EMA N/A (Mid Term) N/A
200 Day EMA N/A (Long Term) N/A
MACD (12 26 9) N/A N/A
RSI (14) N/A N/A
MFI (14) N/A N/A
CCI (20) N/A N/A
ADX (14) N/A N/A
10 Day Avg Volume N/A
ARVINDREM Other Details
Segment EQ
Market Capital 0.00
Sector Pharmaceuticals
Offical website
Arvind Remedies Ltd updates on strike by workers   Equity Bulls   - 04th Mar 15
Arvind Remedies: Outcome of board meeting   - 28th Feb 15
Coronet Labs Pvt. Ltd. ceases to be subsidiary of Arvind Remedies Ltd   Equity Bulls   - 17th Feb 15
Arvind Remedies   - 03rd Feb 15
Arvind Remedies Limited   - 06th Jan 15
Arvind Remedies: Updates on strike by workers at Kakkalur   - 05th Jan 15
Buy Arvind Remedies; target of Rs 100: Ventura   - 17th Oct 14
Arvind Remedies hits the roof on decision to withdraw demerger plan   Hindu Business Line   - 13th Aug 14
Arvind Remedies' new plant to start by year-end   Business Standard   - 26th Jun 13
Arvind Remedies sets up Rs. 250-cr plant to tap US market   Hindu Business Line   - 25th Jun 13
Interactive Technical Analysis Chart Arvind Remedies Limited ( ARVINDREM NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from
Your Comments and Response on Arvind Remedies Limited
ARVINDREM Business Profile
Arvind Remedies is in the Pharmaceuticals sector. Arvind Remedies Ltd forayed into the world of quality healthcare in 1988 under the dynamic and ambitious stewardship of Dr.Arvind Shah, Managing Director and CEO. Having established our credibility as a company committed to providing world-class healthcare products, we went Public in April 1996 getting listed in Bombay Stock Exchange & National Stock Exchange in Mumbai, Ahmedabad and Chennai Stock Exchanges. The Public Issue comprised of 30 Lakhs Equity Shares priced at Rs.10/- each at a premium of Rs.20/- per share. In the year 1995 the company was converted to limited company. In January 2001, the Company followed this up with a Rights Issue of 14.86 Lakhs Equity Shares of Rs.10/- each for cash at a premium of Rs.90/- per share. During the year 2010-11 the company has increased its authorized share capital to Rs.66 Crores and paid up capital for Rs.48.23 crores with the addition of preferential issue of 22.50 crores equity shares of Rs.1 each at premium of Rs.1.25 per share. During the year 2012-13 company has started commercial operation of its new facility at irungatukottai,Kancheepuram Dt,Tamil nadu , which is plan for registration under USFDA Arvind Remedies' Indian client portfolio includes prestigious Defence Establishments, ESI, CGHS, Central and State Government Institutions, Public Sector Companies, P&T, Railways and World Bank Projects. We have also won international acceptance and recognition with our exports to Africa, Commonwealth of Independent States and Asian countries The current market capitalisation stands at Rs 307.14 crore.The company has reported a standalone sales of Rs 219.65 crore and a Net Profit of Rs 13.13 crore for the quarter ended Sep 2013. The company management includes B Arvind Shah - Managing Director & CEO, Chandra Ravindran - Whole Time Director, C M K Reddy - Director, R Raja Mohan - Director, V R Mehta - Director, Ankur Agarwal - Executive Director, Sudhir Chandra - Additional Director. It is listed on the BSE with a BSE Code of 531823 and the NSE with an NSE Code of ARVINDREM. Its Registered office is at 190, Poonamallee High Road , Chennai (Madras),Tamil Nadu - 600084.